ARTICLE | Company News
U.S. approval for Iroko's Tivorbex
February 26, 2014 1:30 AM UTC
FDA approved an NDA from Iroko Pharmaceuticals LLC (Philadelphia, Pa.) for Tivorbex indomethacin (formerly Tiforbex) to treat mild to moderate acute pain. The product is a submicron formulation of the...